 |
 |
 |
||
 |
April 19, 2010 |  |
||
 |
 |
|||
 Saad Omer, MBBS, MPH, PhD |
|
|||
|
|
|||
 Guido Silvestri, PhD |
Leading HIV Scientist is Newest GRA Eminent Scholar Guido Silvestri, a leading scientist in studies of HIV and the related primate virus SIV, will become Emory's 11th Georgia Research Alliance Eminent Scholar this June. Silvestri will lead the Yerkes Division of Microbiology and Immunology and work to develop new therapies and vaccines for chronic diseases. Read more... |
|||
|
|
|||
 Raymond Schinazi, PhD |
|
HIV Drugs Could Work Against Prostate Cancer A virus called XMRV has been found in biopsies from some prostate cancer patients. Now, in laboratory research, four drugs already used to treat HIV infection can inhibit XMRV. If a stronger link is proven between XMRV and prostate cancer, HIV drugs may provide a possible treatment. Read more... |
||
|
|
|||
 Emory Product Pipeline |
Celebration of Technology and Innovation Recognizes Tech Transfer Success Emory's annual tech transfer event recognized biotech innovations and entrepreneurs in neurology, cancer, ophthalmology, and emergency medicine. Speaker Joseph Allen, the key senate staffer securing passage of the Bayh-Dole Act, discussed the process of turning university research into products for patients and consumers. Read more... |
|||
|
|
|||
 Allan Levey, MD, PhDJames Lah, MD, PhD |
Two Birds with One Stone to Treat Alzheimer's Drugs now available to treat Alzheimer's address its symptoms, including memory problems. But to target the underlying mechanism of neurodegeneration, scientists are looking at compounds that could boost the function of certain brain circuits and also modify the production of toxic beta-amyloid protein. Read more... |
|||
 |
 |
|||